Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Chromocell Therapeutics Corp
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001753926-24-000980 (33 Act) Size: 556 KB |
May-15-2024 | 24951226 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001753926-24-000978 (33 Act) Size: 557 KB |
May-15-2024 | 24950978 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001753926-24-000976 (34 Act) Size: 3887 KB |
May-15-2024 | 24950456 |
POS EX | Document | Post-effective amendment filed solely to add exhibits to a registration statement Acc-no: 0001753926-24-000746 (33 Act) Size: 49 KB |
Apr-17-2024 | 24848946 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001753926-24-000744 (33 Act) Size: 1632 KB |
Apr-17-2024 | 24848893 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001753926-24-000742 (33 Act) Size: 1633 KB |
Apr-17-2024 | 24848883 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001753926-24-000740 (34 Act) Size: 5167 KB |
Apr-16-2024 | 24848428 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001753926-24-000729 (33 Act) Size: 206 KB |
Apr-15-2024 | 24842819 |
8-K | Document | Current report filing Acc-no: 0001753926-24-000691 (34 Act) Size: 241 KB |
Apr-09-2024 | 24831216 |
NT 10-K | Document | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001753926-24-000651 (34 Act) Size: 27 KB |
Apr-01-2024 | 24805804 |
8-K | Document | Current report filing Acc-no: 0001753926-24-000584 (34 Act) Size: 223 KB |
Mar-21-2024 | 24769660 |
8-K | Document | Current report filing Acc-no: 0001753926-24-000550 (34 Act) Size: 223 KB |
Mar-18-2024 | 24759006 |
8-K | Document | Current report filing Acc-no: 0001753926-24-000521 (34 Act) Size: 3806 KB |
Mar-13-2024 | 24744613 |
4/A | Document | Amendment to Statement of changes in beneficial ownership of securities Acc-no: 0001753926-24-000518 ( Act) Size: 5 KB |
Mar-12-2024 | |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001753926-24-000459 (34 Act) Size: 56 KB |
Mar-04-2024 | 24715007 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001753926-24-000449 (34 Act) Size: 57 KB |
Mar-01-2024 | 24711640 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001753926-24-000447 (34 Act) Size: 58 KB |
Mar-01-2024 | 24711562 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001753926-24-000445 (34 Act) Size: 56 KB |
Mar-01-2024 | 24711510 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001753926-24-000443 (34 Act) Size: 39 KB |
Mar-01-2024 | 24711486 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001753926-24-000441 (34 Act) Size: 75 KB |
Mar-01-2024 | 24711413 |
Recent 20 filings. View all Chromocell Therapeutics Corp filings
Thanks I look forward to using the product to improve my skin tone
It's being easier working on the website. And I recommend, it's a great website
Very good communication and delivery made within the timeframe I was advised of
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by